Jim Cramer’s 10 Best Stock Picks for Investors Right Now. In this article, we are going to take a look at where Moderna, Inc.

The therapeutic vaccine, codenamed mRNA-4359, is intended to boost people's immunity to a variety of advanced solid tumor ...

Key Takeaways Moderna shares surged Tuesday after Canadian regulators approved the biotech firm’s updated COVID-19 ...

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

The potential of mRNA vaccines was established during the COVID-19 pandemic. Now, a new wave of candidates could soon hit the ...

Moderna shares are moving higher on Tuesday after the company announced that Health Canada approved its updated COVID-19 ...

SPIKEVAX® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians ...

TORONTO — Health Canada has authorized Moderna’s updated COVID-19 vaccine that protects against currently circulating ...

Moderna shares have dropped by over -41.67% since I last covered them over the summer. See why I continue to rate MRNA stock ...

Moderna Inc. (NASDAQ:MRNA) is navigating challenges as its Covid vaccine business declines. Moderna Inc. (NASDAQ:MRNA)’s second commercially available product, RSV vaccines for seniors ...

In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other Jim Cramer's best stocks for investors. In a recent episode of Mad Money, Jim Cramer ...

RBC Capital analyst Luca Issi maintained a Hold rating on Moderna (MRNA – Research Report) today and set a price target of $75.00. The ...